| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 178.9 | 259.4 | 137.2 |
| Other income | 2.6 | 5.0 | 3.4 |
| Total income | 181.5 | 264.4 | 140.6 |
| Profit before exceptional items & tax | 30.0 | 61.6 | 12.6 |
| Profit before tax | 30.0 | 61.6 | 12.6 |
| Net profit | 23.0 | 47.5 | 9.6 |
| Operating margin | 16.5% | 23.3% | 9.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +139.60% |
|---|---|
| Net profit, quarter on quarter | -51.60% |
| Revenue, year on year | +30.40% |
BSE results filing, NSE: VENUSREM. Figures extracted from the filing.
Venus Remedies Ltd: key numbers
- Share price
- ₹1,769.40
- Market cap
- ₹2,365 Cr
- Revenue (annual)
- ₹769.6 Cr
- Net profit (annual)
- ₹102.8 Cr
- P/E (TTM)
- 20.4×Sector 47.3×
- Promoter holding
- 41.76%+0.00% QoQ
- FII holding
- 2.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venus Remedies Ltd
All →Venus Remedies Other Announcement
Venus Remedies Limited has informed the exchanges about its social media posts regarding a special window for the re-lodgement of physical share transfer requests.
Venus Remedies Management Change
Venus Remedies Ltd announced the appointment and re-appointment of several Directors, including Executive and Independent Directors, following approval at its 37th Annual General Meeting.
Venus Remedies Annual General Meeting
Venus Remedies Ltd held its 37th Annual General Meeting on August 20, 2026, via video conferencing. The meeting addressed ordinary and special resolutions regarding company business.
Venus Remedies Other Announcement
Venus Remedies informed the exchanges about their social media communications regarding a special window for re-lodgement of physical share transfer requests.
Venus Remedies Annual General Meeting
Venus Remedies Ltd announced its 37th Annual General Meeting scheduled for August 20, 2026, to consider financial statements, dividends, and director re-appointments.
Venus Remedies Board Meeting Date
Venus Remedies will hold a board meeting on July 20, 2026. The board will consider and approve unaudited financial results for the June quarter.